PharmaEssentia Revenue

PharmaEssentia had revenue of 3.26B TWD in the quarter ending March 31, 2025, with 97.00% growth. This brings the company's revenue in the last twelve months to 11.34B, up 93.12% year-over-year. In the year 2024, PharmaEssentia had annual revenue of 9.73B with 90.67% growth.

Revenue (ttm)

11.34B

Revenue Growth

+93.12%

P/S Ratio

15.49

Revenue / Employee

86.55M

Employees

131

Market Cap

175.63B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.73B	4.63B	90.67%
Dec 31, 2023	5.11B	2.22B	77.15%
Dec 31, 2022	2.88B	2.23B	339.00%
Dec 31, 2021	656.51M	99.25M	17.81%
Dec 31, 2020	557.26M	251.57M	82.29%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Caliway Biopharmaceuticals	40.47M
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Polaris Group	87.67M
Oneness Biotech	117.33M
Center Laboratories	1.63B
Lumosa Therapeutics	43.59M
TaiMed Biologics	607.46M

Revenue Rankings

PharmaEssentia News

5 months ago - ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b) - Benzinga

More News